Sialoadhesin is a macrophage-restricted, sialic acid-dependent receptor of 185 kD that binds to the oligosaccharide sequence NeuAca2,3Gal on cell surface glycoconjugates. Invest. 1995. 95:635-643.)
Introduction
Carbohydrate-binding proteins are important in a wide variety of biological processes involving specific cell-cell interactions. In mammals, the best characterized carbohydrate-binding proteins are the selectins, which are involved in leukocyte-endothelial cell interactions and contain a C-type lectin domain at the amino terminus (1).
RBC, red blood cell. diate diverse recognition functions at the cell surface via both homotypic and heterotypic interactions. In general, these molecular interactions are considered to be protein-protein in nature, involving in each case a relatively restricted range of "ligand" counter receptors. Recently, however, it has become apparent that certain members of the IgSF can also function as lectinlike receptors by binding to specific carbohydrate determinants present on a potentially wide range of counter receptors (2) (3) (4) . The best established of these is the human B cell-restricted antigen, CD22, which has seven Ig-like domains and can function as a sialic acid-dependent adhesion molecule (4, 5) . Upon transient expression in monkey COS cells, human CD22 has been shown capable of binding T cells, B cells, monocytes, granulocytes, and erythrocytes (RBCs) in a sialic acid-dependent manner, via recognition of NeuAca2,6Gal,81,4Glc (NAc) in N-linked glycans on a wide range of cell surface glycoproteins (6) (7) (8) .
Sialoadhesin is a macrophage (M4)-restricted plasma membrane receptor with an apparent Mr of 185K. It has been characterized as a sialic acid-binding protein that specifically recognizes the oligosaccharide sequences NeuAca2,3Gal1,1,3-GalNAc and NeuAca2,3Gal/31,3(4)GlcNAc in either glycoproteins or glycolipids (9, 10) . Recent cDNA cloning has revealed that sialoadhesin is a new member of the IgSF (3). With 17 extracellular Ig-like domains, it is the largest cell surface member of this family so far described. Importantly, the first four amino-terminal Ig-like domains of sialoadhesin share -50% sequence similarity with a distinct subgroup of the IgSF that includes CD22. This establishes the fact that members of the IgSF can mediate cellular interactions through recognition of specific cell surface glycoconjugates ( 11) .
The distribution and properties of sialoadhesin indicate that the receptor functions in vivo as a MO-restricted cellular interaction molecule that binds appropriate sialylated ligands on developing myeloid cells in the bone marrow (BM) and lymphocyte subpopulations in lymphoid tissues (12, 13 Purification of sialoadhesin. Sialoadhesin was purified as described previously (9) , with the following modifications: 2% CHAPS was used instead of sodium deoxycholate as the detergent, and the total spleen lysate was cleared of nuclei and insoluble material by centrifugation at 20,000 g for 30 min. The yield of sialoadhesin was -700 Ig per 100 g of spleens, and purity was estimated at 95% by SDS-PAGE.
Antibodies. IgG, F(ab')2, and Fab fragments of SER-4 (IgG2a), a rat mAb directed against sialoadhesin, were prepared as described previously (14) . Purified IgGs from 5C1, a rat IgG2c mAb against the murine MO-restricted F4/80 antigen, and 5C6, a rat IgG2b against murine CD11a (15) , were used as negative controls in some experiments. GK1.5 (anti-CD4), TIB 165 (anti-CD8), and TIB 146 (anti-B220) rat mAbs were generously provided by Dr. J.M. Austyn (Oxford University, UK). NIMP-R14 rat anti-mouse neutrophil mAb (16) was a kind gift of Dr. C.J. Sanderson (University of Western Australia). The rat myeloma cell, Y3, was provided by Dr. C. Milstein (Cambridge University, UK).
To prepare a new panel of mAbs directed to different epitopes of sialoadhesin, an AO rat was immunized with purified sialoadhesin, using a regime described previously (14) except that the final injection was intrasplenic. Hybridoma supernatants were screened for their ability to block sheep RBC binding to mouse serum-induced peritoneal MO (14) .
10 stable hybridomas were cloned. Their designations and isotypes are as follows: 1C2 (IgG2a), 1C3 (IgGI), 2D5 (IgGi), 2F8 (IgGl), 3B3 (IgGI), 3B8 (IgG2a), 3D6 (IgG2a), 4D5 (IgGI), 4F7 (IgGI), and 5D8 (IgGI).
IgGs from the panel of mAbs were purified from ascites by sodium sulfate precipitation and FPLC ion exchange chromatography using a Mono-Q column. Fab and F(ab' )2 fragments were prepared as described previously for , except that FPLC Mono-Q ion exchange chromatography was used instead of DEAE-Sephacel.
A rabbit polyclonal anti-sialoadhesin antiserum (R6.2-4) was prepared by immunization of an albino rabbit with purified sialoadhesin. IgG was purified from the pooled serum by chromatography on protein A-Sepharose, and Fab and F(ab')2 fragments were prepared by standard methods.
The purities of IgGs and fragments were consistently > 95%, as assessed by Coomassie blue-stained SDS-PAGE gels. Protein concentrations were determined by measuring absorbance at 280 nm, assuming an extinction coefficient of 1.4.
Epitope mapping. Thioglycollate-elicited peritoneal M4 induced to express sialoadhesin were used as targets for epitope mapping (14) . Cells were fixed in methanol for 10 min immediately before the binding assay, and nonspecific sites were blocked in PBS + 1% BSA for 60 min at 37°C. mAbs were iodinated by the lodogen method to specific activities of 250 Bq/ng. Fixed MO were preincubated for 60 min with unlabeled mAb at 20 Itg/ml, and 1251I-labeled mAbs were added to the wells at a final concentration of 72 kBq/ml (-0.3 Itg/ml), in the continued presence of the unlabeled mAb. After 60 min at room temperature, wells were rinsed five times with PBS + 0.1% BSA, and the bound radioactivity was solubilized by addition of 0.1 N NaOH and counted in a Berthold gamma counter.
Preparation of cells. Human RBCs (type A or AB) were prepared fresh from the same donors and stored in Alsever's solution. Sheep erythrocytes were purchased from Gibco Biocult Ltd. and used within 2 wk. Sialidase treatment of cells was performed as described previously (9) . Resident peritoneal MO were obtained as described (17 Production of Fc-adhesins. cDNAs encoding full-length sialoadhesin and murine CD22 were cloned into pcDNA I/Amp as described (3, 11) . To produce Fc-adhesins, cDNA fragments encoding four (sialoadhesin) or three (CD22) extracellular domains were generated by PCR from the full-length cDNAs, cloned into the pIG vector, expressed in COS cells, and purified on protein A-Sepharose as described (1 1, 19 of the same buffer. After 30 min at room temperature, the nonadherent and loosely adherent cells were removed with three washes. For the single-cell, qualitative binding assays, the same conditions were used, except that the ttCr labeling step was omitted and the adherent cells were fixed at the end of the assay prior to immunocytochemistry. The specificity of binding to Fc-sialoadhesin was assessed in all experiments by a 60-min preincubation of coated wells with SER-4 and 3D6 F(ab')2 fragments, each at 20 ,sg/ml. Nonspecific binding was also assessed using Fc-NCAM-coated wells.
COS cell binding assays. COS cells were transfected with plasmids encoding full-length sialoadhesin using DEAE-dextran (19) . Binding assays were performed with BM cells as described (3) . The tivity similar to that described previously for octylglucoside (9) . Human RBCs were used in initial experiments, since they were shown previously to be excellent ligands for sialoadhesin (9) and do not express Fc receptors that could interfere with the assay. 3D6 and 1C2 IgGs showed complete inhibition of '251-sialoadhesin binding at antibody concentrations as low as 0.1 sg/ml (Fig. 1 a) 2 a) . For all cell types, binding was > 90% inhibitable by 3D6 and, where studied, by pretreatment of the cells with V. cholerae sialidase (data not shown). Unexpectedly, inflammatory neutrophils showed the highest level of binding, being approximately twofold higher than BM cells, fourfold higher than lymphocytes, and fivefold higher than thymocytes (Fig. 2 a) . The high binding observed with inflammatory neutrophils raised the possibility that normal, circulating neutrophils are strongly recognized by sialoadhesin. Alternatively, neutrophil activation during recruitment could result in high levels of binding due to increased surface expression of ligands. To distinguish between these two possibilities, neutrophils were enriched Fig. 3 and Table III) . Binding assays to M4 were then performed with blood leukocytes, P4 neutrophils, lymphocytes isolated from mesenteric lymph nodes, and thymocytes (Fig. 3) . In contrast to binding assays with the purified receptor, binding assays with MO resulted in a variable but significant "background" binding that was not inhibitable by 3D6 (Fig. 3) . This was most noticeable for P4 neutrophils, thymocytes, and mesenteric lymphocytes and indicates a role for other divalent cation-independent MO adhesion receptors in binding to these cell types. erties of both receptors. These experiments were done with recombinant forms of CD22 and sialoadhesin containing the first three or four extracellular domains, respectively, fused to the Fc portion of human IgGi (19) . In other studies, these truncated Fc-adhesins have been shown to exhibit full sialic acid-dependent binding activity to human RBCs when compared with the respective full-length forms ( 11).
In initial experiments, "'I1-labeled Fc-adhesins exhibited no detectable binding activity to cells in fluid-phase binding assays.
To increase the avidity of the normally dimeric Fc-adhesins, fluid-phase binding assays were performed using radiolabeled Fc-adhesins that had been precomplexed with an equimolar concentration of anti-human IgG antiserum. This resulted in stable, specific binding to cells that was temperature independent since, similar binding of complexed Fc-sialoadhesin and Fc-CD22 was observed at 4°C and room temperature. For all cell types examined (Fig. 4) , binding of both Fc-sialoadhesin and Fc-CD22 was sialic acid dependent, but the patterns of cell recognition were distinct. Similarly to the native protein, Fcsialoadhesin bound most strongly to P4 neutrophils, with intermediate binding to BM cells and blood leukocytes, whereas lymphocytes and thymocytes bound poorly. In striking contrast, Fc-CD22 bound most strongly to lymphocytes and blood leukocytes, whereas binding to P4 neutrophils was weak, with intermediate binding to BM cells and thymocytes.
These studies indicate that sialoadhesin binds preferentially to cells of the granulocytic lineage, whereas CD22 shows preference for lymphocytes. To obtain direct evidence for this, we performed cell adhesion assays on plastic wells that had been coated with Fc-adhesins and then characterized the cells that were specifically bound. In this system, binding of cells depended on the coating concentration, with optimal binding being _ buffer-treated ] sialidase-treated observed at around 10 nM Fc-adhesin (Fig. 5 a) . No binding was observed with wells coated with Fc-NCAM as a negative control (Fig. 5 a) . Binding of cells to Fc-sialoadhesin was sialic acid dependent (data not shown) and inhibited to background levels in the presence of a mixture of F(ab')2 fragments from SER-4 and 3D6 (Fig. 5 b) . When the various hemopoietic cell populations were compared, the rank order of binding to Fcsialoadhesin was the same as that observed in all other assays (Fig. 5 b) .
For the single-cell analysis, we used BM cells and blood leukocytes since these are complex mixtures of cells that allowed us to determine whether particular subpopulations of cells were selected by Fc-sialoadhesin and Fc-CD22. As shown in Table IV , Fc-sialoadhesin selectively bound to cells of the granulocytic lineage. Thus, blood leukocytes contain 20% neutrophils, 70% lymphocytes, and 5% monocytes, yet up to 97% of the cells bound were neutrophils, as defined by the NIMP-R14 mAb (16) and Giemsa staining. In contrast, CD22 showed a striking preference for lymphocytes. This was most clearly seen with the BM cell suspensions in which > 70% of the cells bound to Fc-CD22 were developing B lymphocytes as defined by the B220 mAb TIB 146, compared with only 15% B lymphocytes in the total BM cell suspension (Table IV) .
Binding of BM cells to COS cells transfected with sialoadhesin cDNA. The single-cell analysis described above was extended to COS cells that had been transfected transiently with a cDNA encoding full-length sialoadhesin. BM cells bound only to the transfected cells, and this was sialic acid dependent and mAb inhibitable (data not shown). Staining of the bound cells with Giemsa (Fig. 6 a) or by immunoperoxidase labeling with the neutrophil marker NIMP-R14 (Fig. 6 b) (32, 33) . Cooperativity between sialoadhesin and other receptors in clearance of neutrophils would be analogous to the coordinated interaction of endothelial cell and neutrophil adhesion receptors during neutrophil margination and extravasation in acute inflammation (reviewed by Butcher [34] ).
In conclusion, our study demonstrates that cell type-specific glycosylation of hemopoietic cells results in selective interactions of developing and mature granulocytes with sialoadhesin expressed by M45. Importantly, the highly restricted expression pattern of sialoadhesin would limit these cellular interactions to Mo populations within hemopoietic and secondary lymphoid tissues and possibly at sites of inflammation.
